Over a week ago
Options
Latest data shows the…
Latest data shows the largest indicative borrow rate increases among liquid option names include: TPG Pace Beneficial Finance (TPGY) 14.18% +0.97, Sempra Energy (SRE) 1.16% +0.91, Titan Pharmaceuticals (TTNP) 28.04% +0.77, India Globalization Capital (IGC) 21.46% +0.63, FMC Technologies (FTI) 3.12% +0.44, Playtika Holding Corp (PLTK) 0.75% +0.40, Global X Cannabis (POTX) 8.71% +0.36, BioNTech SE (BNTX) 1.50% +0.21, U.S. Natural Gas Fund (UNG) 1.46% +0.20, and Aeterna Zentaris (AEZS) 14.79% +0.16.
Show Hide Related Items >> <<
UNG United States Natural Gas Fund 12/28/20 United States Natural Gas Fund falls -10.7% 12/28/20 United States Natural Gas Fund falls -10.6% 12/07/20 United States Natural Gas Fund falls -6.6% 12/03/20 United States Natural Gas Fund falls -7.4% TTNP Titan Pharmaceuticals 02/01/21 Titan announce results from studies of JT-09 opioid agonist peptide 12/16/20 Titan Pharmaceuticals regains compliance with Nasdaq listing requirements 11/30/20 Titan Pharmaceuticals announces 1-for-30 reverse stock split 11/02/20 Titan completes agreement to settle its debt obligations TPGY TPG Pace Beneficial Finance 01/26/21 TPG Pace Beneficial Finance falls 10.5% 12/21/20 Charging names' rise attributed to infrastructure details in stimulus bill 12/11/20 TPG Pace Beneficial Finance soars after combination with EVBox Group 12/02/20 Sempra Energy announces transactions to form new infrastructure platform 11/17/20 TechnipFMC receives notice to proceed for EPC contract 11/17/20 Sempra Energy joint venture reaches FID for LNG export project IGC India Globalization Capital 11/24/20 Cannabis stocks soar as Trump approves start of transition to Biden 11/23/20 IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients 11/23/20 IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients 02/16/21 TechnipFMC falls -20.7% 02/16/21 TechnipFMC falls -18.3% 02/16/21 TechnipFMC falls -18.1% 02/15/21 TechnipFMC completes separation of two independent, publicly traded companies 02/17/21 Pfizer, BioNTech to supply EC with 200M additional COVID-19 vaccine doses 02/12/21 BioNTech, Pfizer to supply U.S. with 100M additional doses of COVID-19 vaccine 02/10/21 BioNTech provides update on vaccine production at Marburg manufacturing site 02/01/21 BioNTech, Pfizer boost 2021 Covid vaccine output to 2B from 1.3B doses 02/02/21 Aeterna Zentaris signs option agreement for potential German COVID-19 vaccine 01/28/21 Aeterna Zentaris licenses exclusive rights of specific modifying proteins 01/26/21 Aeterna Zentaris given Nasdaq notice of additional 180 days to regain compliance 12/07/20 Aeterna Zentaris enters European licensing agreement with Consilient Health TPGY TPG Pace Beneficial Finance 01/14/21 Wells Fargo Sempra Energy upgraded to Overweight from Equal Weight at Wells Fargo 01/14/21 Wells Fargo Sempra Energy upgraded to Overweight from Equal Weight at Wells Fargo 01/05/21 Barclays Sempra Energy price target lowered to $149 from $159 at Barclays 12/16/20 Mizuho Sempra Energy price target raised to $137 from $119 at Mizuho TTNP Titan Pharmaceuticals 08/17/20 Maxim Titan Pharmaceuticals downgraded to Hold from Buy at Maxim 08/14/20 Maxim Titan Pharmaceuticals downgraded to Hold from Buy at Maxim IGC India Globalization Capital 02/02/21 Craig-Hallum Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum 01/29/21 Stifel 'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel 12/04/20 Alliance Global Partners Alliance Global sees low odds of MORE Act passing this congressional session 12/02/20 Alliance Global Partners Alliance Global Partners sees UN cannabis reclassification helping legalization 02/01/21 Berenberg TechnipFMC downgraded to Hold from Buy at Berenberg 01/29/21 Morgan Stanley TechnipFMC price target raised to EUR 11.40 from EUR 8.60 at Morgan Stanley 01/13/21 Citi TechnipFMC price target raised to EUR 12.50 at Citi 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Wedbush Wedbush bullish on Playtika, initiates with an Outperform 02/10/21 Cowen Playtika initiated with an Outperform at Cowen 02/09/21 Wedbush Playtika initiated with an Outperform at Wedbush 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi UNG United States Natural Gas Fund TTNP Titan Pharmaceuticals 11/16/20 Titan Pharmaceuticals reports Q3 EPS (5c), consensus (3c) 11/05/20 Sempra Energy backs FY20 adj. EPS view $7.20-$7.80, consensus $7.66 11/05/20 Sempra Energy reports Q3 adj. EPS $1.31, consensus $1.52 IGC India Globalization Capital 08/26/20 Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219 10/21/20 TechnipFMC sees FY20 Subsea revenue $5.3B-$5.6B 10/21/20 TechnipFMC reports Q3 adjusted EPS 16c, consensus 22c 11/06/20 Aeterna Zentaris reports Q3 EPS (2c) vs. (2c) last year
On The Fly
Show Hide Related Items >> <<
02/09/21 Virgin Galactic establishes Space Advisory Board 02/02/21 Virgin Galactic near lows of day after SpaceX starship test flight fails 02/01/21 Virgin Galactic provides flight test program update 01/25/21 Virgin Galactic trading resumes 10/23/20 Penske Automotive CFO sells 8K shares of common stock 10/14/20 Penske Automotive reinstates dividend of 42c per share $376.79 / -14.18 (-3.63%)
02/09/21 Lithia Motors acquires two stores in Florida from Fields Auto Group 12/01/20 Lithia Motors acquireds Ramsey Subaru and Mazda in Iowa 11/17/20 LAD acquires Sterling Luxury Group in Loudoun County Virginia 11/10/20 Lithia Motors acquires $1.4B in revenues from Keyes Automotive Group 01/12/21 CarMax launches Love Your Car Guarantee 12/22/20 CarMax CEO says 'our fundamentals remain robust' 12/22/20 CarMax expects to open 8-10 stores in FY22 12/22/20 CarMax reports Q3 used unit sales in comparable stores down 0.8% 02/04/21 Group 1 Automotive CEO says 'massive productivity improvements' in Q4 12/07/20 Group 1 Automotive VP Delongchamps sells almost $380K in shares 11/18/20 Group 1 Automotive reinstates quarterly dividend at 30c per share 10/06/20 Group 1 Automotive rises 14.3% 01/26/21 Canopy Growth launches new line Martha Stewart CBD for Pet 01/14/21 Canopy Growth files early warning report regarding TerrAscend Corp. 01/07/21 Constellation recognized $770M increase in fair value of Canopy investments 12/21/20 Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement 02/09/21 Akamai drops 6% to $110.70 after Q4 results, FY guidance 02/09/21 Akamai says expects to see traffic continue to grow in 2021 02/09/21 Akamai CEO says strong Q4 performance 'capped off an excellent year' 02/09/21 Akamai announces organizational realignment 11/16/20 Asbury Automotive reschedules call to unveil end-to-end car-buying solution 10/27/20 Asbury Automotive reports Q3 new gross profit per vehicle up 73% to $2,468 $376.79 / -14.18 (-3.63%)
02/10/21 Fly Intel: Top five analyst downgrades 02/10/21 Morgan Stanley Morgan Stanley cuts Lithia Motors to sell with shares near bull case 02/09/21 Morgan Stanley Lithia Motors downgraded to Underweight from Equal Weight at Morgan Stanley 02/04/21 Craig-Hallum Lithia Motors price target raised to $450 from $350 at Craig-Hallum 02/03/21 Craig-Hallum Asbury Automotive price target raised to $180 from $150 at Craig-Hallum 01/15/21 Truist Asbury Automotive price target raised to $180 from $130 at Truist 01/15/21 JPMorgan Asbury Automotive price target raised to $145 from $125 at JPMorgan 12/07/20 Morgan Stanley Morgan Stanley upgrades Asbury, downgrades Lithia in auto dealer rating shake-up 10/19/20 Seaport Global Group 1 Automotive initiated with a Buy at Seaport Global 08/27/20 Benchmark Benchmark sees more strong earnings from auto dealers, ups targets in group 01/15/21 Truist Penske Automotive price target raised to $75 from $65 at Truist 10/19/20 Seaport Global Penske Automotive initiated with a Buy at Seaport Global 01/19/21 Northcoast CarMax upgraded to Buy from Neutral at Northcoast 12/28/20 Argus CarMax price target raised to $110 from $105 at Argus 12/23/20 Morgan Stanley CarMax price target lowered to $165 from $180 at Morgan Stanley 02/10/21 MKM Partners Canopy Growth price target raised to C$55 from C$28 at MKM Partners 02/10/21 Stifel Stifel stays at Sell on Canopy Growth after 'perplexing outperformance' 02/10/21 Canaccord Canopy Growth downgraded to Sell on valuation at Canaccord 02/10/21 Craig-Hallum Akamai downgraded to Hold at Craig-Hallum 02/10/21 Credit Suisse Akamai price target raised to $115 from $105 at Credit Suisse 02/10/21 Craig-Hallum Akamai downgraded to Hold from Buy at Craig-Hallum 02/10/21 Fly Intel: Top five analyst initiations 02/10/21 Wedbush Wedbush bullish on Playtika, initiates with an Outperform 02/10/21 Cowen Playtika initiated with an Outperform at Cowen 02/09/21 Wedbush Playtika initiated with an Outperform at Wedbush 02/09/21 UBS Virgin Galactic downgraded to Neutral from Buy at UBS 02/01/21 Fly Intel: Top five analyst downgrades 02/01/21 Morgan Stanley Morgan Stanley downgrades Virgin Galactic to Equal Weight, sees 35% downside 02/01/21 Morgan Stanley Virgin Galactic downgraded to Equal Weight from Overweight at Morgan Stanley 11/05/20 Virgin Galactic reports Q3 EPS (34c), consensus (26c) 02/10/21 Penske Automotive reports Q4 EPS $2.49, consensus $2.13 10/22/20 Penske Automotive reports Q3 ex-items EPS $2.87, consensus $1.56 $376.79 / -14.18 (-3.63%)
02/03/21 Lithia Motors reports Q4 adjusted EPS $5.46, consensus $5.06 10/21/20 Lithia Motors reports Q3 adj. EPS $6.89, consensus $5.86 09/29/20 Lithia Motors reports preliminary Q3 EPS $6.10-$6.40, consensus $4.23 12/22/20 CarMax reports Q3 EPS $1.42, consensus $1.14 12/21/20 Notable companies reporting before tomorrow's open 09/24/20 CarMax reports Q2 EPS $1.79, consensus $1.08 02/04/21 Group 1 Automotive reports Q4 adjusted EPS $5.66, consensus $5.82 10/29/20 Group 1 Automotive reports Q3 adjusted EPS $6.97, consensus $6.07 10/06/20 Group 1 Automotive sees Q3 adjusted EPS $6.40-$6.80, consensus $3.51 02/09/21 Canopy Growth reports Q3 EPS (C$2.43) vs (C$0.26) last year 01/07/21 Constellation Brands reports Q3 adjusted EPS ex. Canopy $3.16, consensus $2.39 11/09/20 Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year 10/01/20 Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91 02/09/21 Akamai sees FY21 EPS $5.33-$5.46, consensus $5.46 02/09/21 Akamai sees Q1 EPS $1.28-$1.31, consensus $1.29 02/09/21 Akamai reports Q4 adjusted EPS $1.33, consensus $1.31 02/09/21 Notable companies reporting after market close 02/02/21 Asbury Automotive reports Q4 adjusted EPS $4.44, consensus $4.14 10/27/20 Asbury Automotive reports Q3 adjusted EPS $4.08, consensus $3.38 10/14/20 Asbury Automotive sees Q3 EPS $4.00-$4.08, consensus $3.26
Initiation
Catch up on today's…
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Catalyst Biosciences (CBIO) initiated with an Overweight at Piper Sandler. 2. Athenex (ATNX) initiated with an Outperform at Evercore ISI. 3. Tracon Pharmaceuticals (TCON) initiated with a Buy at Maxim. 4. Ocuphire Pharma (OCUP) initiated with a Buy at Canaccord. 5. Playtika (PLTK) initiated with an Outperform at Wedbush and Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Show Hide Related Items >> <<
TCON Tracon Pharmaceuticals 01/19/21 Tracon Pharmaceuticals announces acceptance of Envafolimab NDA in China 12/30/20 Tracon Pharmaceuticals announces NMPA acceptance of envafolimab NDA 12/10/20 Tracon Pharmaceuticals doses first patient in ENVASARC trial 11/23/20 Tracon Pharmaceuticals announces publication of clinical data on TRC102 01/20/21 Ocuphire Pharma reports results from ORION-1 Phase 2 clinical trial 01/06/21 Ocuphire Pharma completes enrollment in MIRA-2 Phase 3 trial of Nyxol 01/05/21 Ocuphire Pharma initiates LYNX-1 Phase 3 study of Nyxol 11/19/20 Ocuphire Pharma enrolls first patient in MIRA-2 Phase 3 trial of Nyxol CBIO Catalyst Biosciences 02/03/21 Catalyst Biosciences presents SQ treatement of bleeds data 12/07/20 Catalyst Biosciences presents Crimson 1 Phase 3 study design 12/02/20 Catalyst Biosciences receives FDA fast track designation for MarzAA 10/14/20 Catalyst Biosciences receives patent for anti-complement Factor 3 portfolio 01/08/21 Athenex CEO Dr. Johnson Lau contracts COVID-19 12/15/20 Athenex announces FDA approval of Klisyri for treatment of actinic keratosis 12/09/20 Athenex presents updated Phase 3 PFS, OS data on oral paclitaxel, encequidar 12/02/20 Athenex unit, Ingenus announce availability of ready to dilute Cyclophosphamide CBIO Catalyst Biosciences 02/10/21 Piper Sandler Catalyst Biosciences initiated with an Overweight at Piper Sandler 02/09/21 JonesTrading Catalyst Biosciences assumed with a Buy at JonesTrading 12/02/20 Raymond James Catalyst Biosciences gets Fast Track for MarzAA, says Raymond James 05/21/20 Raymond James Catalyst Biosciences initiated with an Outperform at Raymond James 02/10/21 Evercore ISI Athenex initiated with an Outperform at Evercore ISI 10/26/20 Fly Intel: Top five analyst initiations 10/26/20 SVB Leerink Athenex initiated with an Outperform at SVB Leerink 09/01/20 RBC Capital Athenex price target raised to $33 from $31 at RBC Capital TCON Tracon Pharmaceuticals 02/10/21 Maxim Tracon Pharmaceuticals initiated with a Buy at Maxim 12/04/20 H.C. Wainwright Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright 09/17/20 H.C. Wainwright Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright 04/24/20 H.C. Wainwright Tracon Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright 02/10/21 Canaccord Canaccord starts Ocuphire Pharma at Buy on lead asset's potential 02/10/21 Canaccord Ocuphire Pharma initiated with a Buy at Canaccord 11/19/20 Cantor Fitzgerald Ocuphire Pharma initiated with an Overweight at Cantor Fitzgerald 02/10/21 Wedbush Wedbush bullish on Playtika, initiates with an Outperform 02/10/21 Cowen Playtika initiated with an Outperform at Cowen 02/09/21 Wedbush Playtika initiated with an Outperform at Wedbush 02/09/21 Fly Intel: Top five analyst initiations TCON Tracon Pharmaceuticals 11/10/20 Tracon Pharmaceuticals reports Q3 EPS (38c), consensus (65c) CBIO Catalyst Biosciences 11/05/20 Catalyst Biosciences reports Q3 EPS (73c), consenus (81c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c)
Initiation
As previously reported,…
As previously reported, Wedbush analyst Michael Pachter initiated coverage of Playtika with an Outperform rating and $42 price target. The analyst views Playtika shares as a compelling investment given the company's best-in-class revenue and profitability, its unrivaled portfolio of genre-leading games, its differentiated live services infrastructure and proprietary Playtika Boost Platform, and a long runway ahead for additional growth.
Show Hide Related Items >> <<
02/10/21 Cowen Playtika initiated with an Outperform at Cowen 02/09/21 Wedbush Playtika initiated with an Outperform at Wedbush 02/09/21 Fly Intel: Top five analyst initiations 02/09/21 UBS Playtika initiated with a Buy at UBS
Initiation
Cowen analyst Doug Creutz…
Cowen analyst Doug Creutz initiated coverage of Playtika with an Outperform rating and $42 price target.
Show Hide Related Items >> <<
02/09/21 Wedbush Playtika initiated with an Outperform at Wedbush 02/09/21 Fly Intel: Top five analyst initiations 02/09/21 UBS Playtika initiated with a Buy at UBS 02/09/21 Morgan Stanley Playtika initiated with an Overweight at Morgan Stanley